VeriChip (now re-branded as PositiveID) was the only Food and Drug Administration (FDA)-approved human-implantable microchip. It was marketed by PositiveID, a subsidiary of Applied Digital Solutions, and it received United States FDA approval in 2004. Its manufacture and marketing were discontinued in 2010. About twice the length of a dime, the device is typically implanted between the shoulder and elbow area of an individual’s right arm. Once scanned at the proper frequency, the VeriChip responds with a unique 16 digit number which could be then linked with information about the user held on a database for identity verification, medical records access and other uses.
Method and system for identification of a medical implant
The invention relates to a method and a system for identification of a medical implant that is inserted into a patient. Identification data of the medical implant is stored in an RFID chip. The RFID chip is inserted into the body of the patient. The RFID chip can be inserted into a different location than the medical implant into the body of the patient or can be arranged on the medical implant. A signal from the RFID chip comprising the identification data of the medical implant is called up by a reading unit.
Guidance for Industry and FDA Staff – Class II Special Controls Guidance Document: Implantable Radio frequency Transponder System for Patient Identification and Health Information
This guidance document was developed as a special control guidance to support the classification of the implantable radiofrequency transponder system for patient identification and health information into class II (special controls). The device is intended to enable access to secure patient identification and corresponding health information in humans . This guidance is issued in conjunction with a Federal Register notice announcing the classification of implantable radiofrequency transponder system for patient identification and health information.
Introducing the GlucoChip™
Taking the capabilities of RFID implantable microchips beyond simple identification, PositiveID received a patent in 2006 for an “Embedded Bio-Sensor System,” that combines an embedded bio-sensor system on an implanted RFID microchip. One potential application of this bio-sensor system is an implantable, bio-sensing RFID microchip that measures glucose levels in the body in real time.
Ethical implications of implantable radiofrequency identification (RFID) tags in humans
Foster KR, Jaeger J
American Journal of Bioethics. 8(8):44-8, 2008 Aug.
This article reviews the use of implantable radiofrequency identification (RFID) tags in humans, focusing on the VeriChip (VeriChip Corporation, Delray Beach, FL) and the associated VeriMed patientidentification system. In addition, various nonmedical applications for implanted RFID tags in humans have been proposed. The technology offers important health and nonhealth benefits, but raises ethical concerns, including privacy and the potential for coercive implantation of RFID tags in individuals. A national discussion is needed to identify the limits of acceptable use of implantable RFID tags in humans before their use becomes widespread and it becomes too late to prevent misuse of this useful but ethically problematic technology.
This has been referenced on the NSW Government Health website which led to the article below being written: